Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 2.38 is 52% below its 5-year average of 5.00, near the low end of its 5-year range (0.00–12.10).
As of the fiscal period ended Tuesday, June 30, 2026. 33.09% above its 12-month average of 1.79.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.38.
CURRENT RATIO
2.38
CURRENT RATIO AVG TTM
1.79
CURRENT RATIO AVG 3Y
3.74
CURRENT RATIO AVG 5Y
5.00
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+33.09%
CURRENT VS 3Y AVG
-36.32%
CURRENT VS 5Y AVG
-52.30%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.49
median of 703 covered companies
CURRENT VS SECTOR MEDIAN
-31.69%
vs the sector median at left
Market Cap
$145.88M
Current Ratio
19.47
TTM Avg
11.39
3Y Avg
11.91
5Y Avg
15.23
Market Cap
$140.03M
Current Ratio
0.79
TTM Avg
0.57
3Y Avg
0.67
5Y Avg
0.95
Market Cap
$139.73M
Current Ratio
3.96
TTM Avg
1.88
3Y Avg
1.73
5Y Avg
2.58
Market Cap
$146.58M
Current Ratio
0.82
TTM Avg
5.49
3Y Avg
4.19
5Y Avg
4.20
Market Cap
$148.36M
Current Ratio
1.23
TTM Avg
1.14
3Y Avg
1.35
5Y Avg
4.96
Market Cap
$136.88M
Current Ratio
2.72
TTM Avg
2.55
3Y Avg
3.48
5Y Avg
5.33
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nyxoah S.A. (NYXH) | $143.10M | 2.38 | 1.79 | 3.74 | 5.00 |
| Immuneering Corporation (IMRX)vs › | $145.88M | 19.47 | 11.39 | 11.91 | 15.23 |
| AirSculpt Technologies, Inc. (AIRS)vs › | $140.03M | 0.79 | 0.57 | 0.67 | 0.95 |
| Fortress Biotech, Inc. (FBIOP)vs › | $139.73M | 3.96 | 1.88 | 1.73 | 2.58 |
| Korsana Biosciences, Inc. (KRSA)vs › | $146.58M | 0.82 | 5.49 | 4.19 | 4.20 |
| Alpha Cognition Inc (ACOG)vs › | $139.63M | 9.03 | 11.82 | 6.24 | 5.64 |
| LifeMD, Inc. (LFMDP)vs › | $147.97M | 0.90 | 1.03 | 0.91 | 1.08 |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $148.36M | 1.23 | 1.14 | 1.35 | 4.96 |
| KORU Medical Systems, Inc. (KRMD)vs › | $136.88M | 2.72 | 2.55 | 3.48 | 5.33 |
| Pyxis Oncology, Inc. (PYXS)vs › | $136.44M | 1.34 | 5.45 | 5.41 | 6.46 |
Current Ratio
2.38
Quick Ratio
2.31
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 2.38 |
| 2026-03-31 | 0.99 |
| 2025-12-31 | 1.25 |
| 2025-09-30 | 1.70 |
| 2025-06-30 | 2.63 |
| 2025-03-31 | 3.59 |
| 2024-12-31 | 4.56 |
| 2024-09-30 | 5.28 |
| 2024-06-30 | 5.47 |
| 2024-03-31 | 3.94 |
| 2023-12-31 | 4.73 |
| 2023-09-30 | 5.97 |
| 2023-06-30 | 6.17 |
| 2023-03-31 | 7.16 |
| 2022-12-31 | 6.72 |
| 2022-09-30 | 5.97 |
| 2022-06-30 | 7.24 |
| 2022-03-31 | 10.41 |
| 2021-12-31 | 12.10 |
| 2021-09-30 | 0.00 |
| 2021-06-30 | 6.68 |
| 2021-03-31 | 10.36 |
| 2020-12-31 | 14.70 |
| 2020-09-30 | 14.70 |
| 2020-06-30 | 6.03 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 1.82 |
| 2019-09-30 | 1.82 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
